Pedro Hernandez has an extensive background in clinical research, innovation, and investment advising, with experience in companies such as Evidenze, Dynamic CRO, ESAME PBS, Healthing Research, Biomedical Systems, and SART-I. Pedro holds a degree in Computer Engineering and Management from Universitat Politècnica de Catalunya.
October, 2023 - present
November, 2020